First Patient Treated with Coronet Soft Tissue Fixation System

October 20, 2020

The first patient treated with Coronet Soft Tissue Fixation System was announced today by CoNextions Inc. Coronet Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain.

The Coronet Soft Tissue Fixation Systems is a tenodesis device intended for the fixation of soft tissue and tendon to bone.  During the Kidner procedure, a surgeon detaches the posterior tibial tendon from the bone and removes the pain-causing bone from the foot.  The posterior tibial tendon is then reattached to the navicular bone and secured with the Coronet.

Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture modalities.  A streamlined delivery system allows for the simultaneous placement of the implant in the bone and soft tissue and provides a knotless repair.  The Coronet is cleared for use by the FDA for the fixation of soft tissue to bone and tissue to tissue throughout numerous anatomical locations.  The first patient was treated by Youngstown, Ohio foot and ankle surgeon, Dr. Lawrence DiDomenico, at The Surgical Hospital at Southwoods.

“The Coronet was remarkably effective in streamlining the posterior tibial tendon reattachment portion of the Kidner procedure,” said Dr. DiDomenico.  “I am excited at the time efficiency the Coronet provided by not having to suture.  I also appreciate the ease of obtaining the appropriate tension with the Coronet versus suture.”

CoNextions Medical is currently launching the Coronet throughout the United States.  The device will be marketed by a network of orthopedic distributors across the country.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”